Despite previous experimental studies that were the basis for our a priori hypotheses, we did not demonstrate any relevant associations of SNPs in the MBL2 or FCN2 gene or MBL protein levels with the early stages or late AMD in our matched case-control study. The gene discussed is MBL2; the disease is age-related macular degeneration.